Results 11 to 20 of about 12,993 (261)

Predictors of early and sustained virological response of viral hepatitis C [PDF]

Romanian Journal of Morphology and Embryology, 2021
Due to complex interplay between host and viral factors, pathogenesis of chronic hepatitis C (CHC) is considered a challenging issue. Infection with hepatitis C virus (HCV) is not confined only to liver but can induce disturbances in many other organs and systems.
Ghenea, Alice Elena, Ungureanu, Anca Marilena, Turculeanu, Adriana, Popescu, Mihaela, Carsote, Mara, Ţieranu, Maria Loredana, Ţieranu, Eugen Nicolae, Vasile, Corina Maria, Cioboată, Ramona, Udriştoiu, Anca Loredana, Alexandru, Dragoş Ovidiu, Sălan, Alex Ioan, Drocaş, Andrei Ioan   +12 more
openaire   +2 more sources

IMPACT OF DIABETIC CONTROL ON ACHIEVING SUSTAINED VIROLOGIC RESPONSE IN CHRONIC HCV PATIENTS RECEIVING DIRECT-ACTING ANTIVIRALS [PDF]

Journal of the Egyptian Society of Parasitology, 2018
This study evaluated the effect of diabetic control on achieving sustained virologic response in patients with chronic hepatitis C virus infection who received direct-acting antivirals (Daclatasvir + Sofosbuvir ± Ribavirin). It included 100 patients with
AHMED MOHAMMED, AYMAN GAMIL, REHAM AL-SWAFF, KHALED ELKARMOUTY   +3 more
doaj   +1 more source

Sofosbuvir-velpatasvir en pacientes mexicanos con hepatitis C: una revisión retrospectiva

Revista de Gastroenterología de México, 2022
Resumen: Introducción: La combinación de sofosbuvir-velpatasvir (SOF/VEL) es una terapia antiviral de acción directa que está autorizada y disponible en México.
J.L. Pérez-Hernández, C.A. Arce-Salinas, R. Lehmann-Mendoza, A. Torre-Delgadillo, G.E. Castro-Narro, E. Cerda-Reyes, M.V. Ramos-Gómez, L. Juárez-Chavez, M. Dehesa-Violante, L.E. Muñoz-Espinosa, L.E. Cisneros-Garza, I. Aiza-Haddad, J.A. Velarde-Ruiz-Velasco, R. Contreras-Omaña, N. García-Casarreal, A. Carmona-Castañeda, F. Higuera-De la Tijera   +16 more
doaj   +1 more source

Effects of vitamin D supplements in patients with chronic hepatitis C: a randomized, multi-center, open label study [PDF]

The Korean Journal of Internal Medicine, 2020
Background/Aims We aimed to assess the role of vitamin D supplementation in the response to pegylated interferon-α (PEG-IFN-α) plus ribavirin (RBV) treatment in patients with chronic hepatitis C (CHC).
Jae Yoon Jeong, Dae Won Jun, Sol Ji Park, Joo Hyun Sohn, Sang Gyune Kim, Se Whan Lee, Soung Won Jeong, Moon Young Kim, Won Kim, Jae-Jun Shim, Hyoung Su Kim, Ki Tae Suk, Sang Bong Ahn   +12 more
doaj   +1 more source

The Combination Therapy with Peg-interferon Alfa and Ribavirin for Chronic Hepatitis C in Korea as an Initial Treatment [PDF]

Kosin Medical Journal, 2012
Objectives The combination therapy with peginterferon and ribavirin has been used to treat chronic hepatitis C for several years in Korea but there is a few report about the results of the treatment.
Dong Hyun Park, Sang Uk Lee, Jin Seok Yu, Jun Seop Lee, Hye Jung Kwon   +4 more
doaj   +1 more source

Safety and effectiveness of direct-acting antivirals in patients with chronic hepatitis C and chronic kidney disease [PDF]

The Korean Journal of Internal Medicine, 2022
Background/Aims To evaluate the effectiveness and safety of direct acting antivirals (DAAs) available in chronic kidney disease (CKD) patients with hepatitis C virus (HCV) infection in Korea.
Ji Eun Ryu, Myeong Jun Song, Seok-Hwan Kim, Jung Hyun Kwon, Sun Hong Yoo, Soon Woo Nam, Hee Chul Nam, Hee Yeon Kim, Chang Wook Kim, Hyun Yang, Si Hyun Bae, Do Seon Song, U Im Chang, Jin Mo Yang, Sung Won Lee, Hae Lim Lee, Soon Kyu Lee, Pil Soo Sung, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon   +20 more
doaj   +1 more source

Sustained virological response according to the type of early virological response in HCV and HCV/HIV

Annals of Hepatology, 2010
The most important factors to predict the sustained virological response (SVR) are the genotype and the fibrosis grade, although there are other predictive factors to be considered, mainly in HCV/HIV coinfected patients.To evaluate different prognostic factors to obtain the SVR in HCV monoinfected and HCV/HIV coinfected genotype 1 patients emphasizing ...
Paulo R. Lerias de Almeida, Angelo Alves de Mattos, Cristiane Valle Tovo   +2 more
openaire   +3 more sources

GAMMA GLUTAMYLTRANSFERASE IMPACT IN THERAPEUTIC RESPONSE OF CHRONIC HEPATITIS C: a systematic review of the literature

Arquivos de Gastroenterologia, 2015
BackgroundThe standard treatment of chronic hepatitis C is the administration of pegylated interferon α2a or α2b in combination with ribavirin, but adverse effects can be observed, as well as the high cost of this therapy. Therefore, there is interest in
Maria de Lourdes Albuquerque de QUEIROGA, Raymundo PARANÁ, José Eymard Moraes de MEDEIROS FILHO, Giovannini Cesar A FIGUEIREDO, Ananda Peixoto de ARAÚJO, Hagley Walson Soares LEITE, Itiel de Souza AQUINO, Leonardo Honório de A MELO NETO   +7 more
doaj   +1 more source

Sustained virological response: A milestone in the treatment of chronic hepatitis C [PDF]

World Journal of Gastroenterology, 2013
To evaluate the long-term eradication of hepatitis C virus (HCV) infection and liver-related complications in chronically infected patients that have achieved sustained virological response.One hundred and fifty subjects with chronic hepatitis C (CHC) or cirrhosis and sustained virological response (SVR) between the years of 1989 and 2008 were enrolled
MORISCO, FILOMENA, Granata R, Stroffolini T, GUARINO, MARIA, Donnarumma L, Gaeta L, Loperto I, Gentile I, Auriemma F, CAPORASO, NICOLA   +9 more
openaire   +2 more sources

The sustained virologic response of nonresponder hepatitis C virus patients with retreatment

Indian Journal of Pathology and Microbiology, 2011
Background: Pegylated interferon and ribavirin combination therapy remain the first-line treatment for chronic hepatitis C virus (HCV) infection. In contrast to the large number of studies in treatment-naive patients, the effectiveness of retreatment in ...
Sila Cetin Akhan, Erdem Gurel, Murat Sayan   +2 more
doaj   +1 more source